Hemab Therapeutics Holdings Inc. Common Stock (COAG)
Stock · NASDAQ · Health Care
$44.77as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$24.9
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
About COAG
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 cli…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 59
- Website
- ir.hemab.com
Fundamentals
- 1-day range
- $44.64$49.37
- Market cap
- $2.44B
- P/E (trailing)
- —
- P/E (forward)
- -17.67
- EPS (trailing)
- $-1.78
- Dividend yield
- —
- Beta
- -0.89
- Avg. volume
- 344.9K
52-week range
$23$55.42
Next earnings: November 16, 2026 · EPS estimate $-0.51
Forecasts
5 analyst ratings
Buy 91%
Hold 9%
Sell 0%
1-year price forecast
High
$65
+45.2%
Median
$60
+34.0%
Low
$58
+29.6%
Hemab Therapeutics Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- COAGHemab Therapeutics Holdings Inc. Common Stock$44.77▼ 9.55%Market cap $2.44BP/E —$23$55.42
- TARSTarsus Pharmaceuticals Inc. Common Stock$71.84▼ 0.12%Market cap $2.81BP/E —$48.2$85.25
- BEAMBeam Therapeutics Inc. Common Stock$29.31▼ 3.84%Market cap $2.81BP/E —$16.02$38.26
- KODKodiak Sciences Inc Common Stock$37.77▼ 3.45%Market cap $2.84BP/E —$8.29$47.84
- MESOMesoblast Limited American Depositary Shares$17.42▼ 4.18%Market cap $2.02BP/E —$1.88$3.31
- RXRXRecursion Pharmaceuticals Inc. Class A Common Stock$3.33▼ 3.20%Market cap $1.69BP/E —$2.77$7.18
- VIRVir Biotechnology Inc. Common Stock$10.83▼ 4.24%Market cap $1.48BP/E —
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings Inc. Common Stock | $2.44B | — | $44.77 | ▼ 9.55% | $23$55.42 |
| TARS Tarsus Pharmaceuticals Inc. Common Stock | $2.81B | — | $71.84 | ▼ 0.12% | $48.2$85.25 |
| BEAM Beam Therapeutics Inc. Common Stock | $2.81B | — | $29.31 | ▼ 3.84% | $16.02$38.26 |
| KOD Kodiak Sciences Inc Common Stock | $2.84B | — | $37.77 | ▼ 3.45% | $8.29$47.84 |
| MESO Mesoblast Limited American Depositary Shares | $2.02B | — | $17.42 | ▼ 4.18% | $1.88$3.31 |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | $1.69B | — | $3.33 | ▼ 3.20% | $2.77$7.18 |
| VIR Vir Biotechnology Inc. Common Stock | $1.48B | — | $10.83 | ▼ 4.24% |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Wedbush Maintains Outperform on Hemab Therapeutics Hldgs, Raises Price Target to $64Benzinga · 8/12/2026
- HC Wainwright & Co. Maintains Buy on Hemab Therapeutics Hldgs, Raises Price Target to $60Benzinga · 8/11/2026
- Hemab Therapeutics Hldgs Q2 EPS $(0.80) Misses $(0.52) EstimateBenzinga · 8/11/2026
Insider Activity
Insider Actions →Acquired
295.5K
Disposed
32.7K
- RA Capital Healthcare Fund LP · June 16, 2026 · Buy61.5K @ $24.98
- RA Capital Healthcare Fund LP · June 15, 2026 · Buy6.1K @ $24.89
- RA Capital Healthcare Fund LP · May 20, 2026 · Buy996 @ $24.94
- RA Capital Healthcare Fund LP · May 19, 2026 · Buy3.8K @ $24.97
- RA Capital Healthcare Fund LP · May 12, 2026 · Buy6.4K @ $24.9
- RA Capital Healthcare Fund LP · May 11, 2026 · Buy25.7K @ $25
- RA Capital Healthcare Fund LP · May 11, 2026 · Buy14.1K @ $24.47
- RA Capital Healthcare Fund LP · May 8, 2026 · Buy1.5K @ $24.98
- RA Capital Healthcare Fund LP · May 7, 2026 · Buy2.0K @ $24.95
- RA Capital Healthcare Fund LP · May 7, 2026 · Buy7.9K @ $24.34
- RA Capital Healthcare Fund LP · May 6, 2026 · Buy53.4K @ $24.83
- RA Capital Healthcare Fund LP · May 6, 2026 · Buy14.6K @ $23.77
- RA Capital Healthcare Fund LP · May 5, 2026 · Buy10.3K @ $25
- RA Capital Healthcare Fund LP · May 5, 2026 · Buy87.1K @ $24.59
- Novo Holdings A/S · May 4, 2026 · Conversion32.7K
See the full, filterable feed with live charts on the MarketWall dashboard.